A Phase 1, Randomized, Placebo-controlled, Single-dose Study to Evaluate the Safety of MEDI7814 in Adult Volunteers
| Status: | Archived |
|---|---|
| Conditions: | Healthy Studies |
| Therapuetic Areas: | Other |
| Healthy: | No |
| Age Range: | Any |
| Updated: | 7/1/2011 |
| Start Date: | February 2012 |
| End Date: | November 2012 |
| Contact: | Sheila Dicostanza |
| Email: | clinicaltrialenquiries@medimmune.com |
This is a Phase 1, study to evaluate the safety and tolerability of single ascending IV
doses of MEDI7814 in healthy adult subjects.
This is a Phase 1, randomized, double-blind, placebo-controlled study to evaluate the safety
and tolerability of single ascending IV doses of MEDI7814 in healthy adult male subjects and
female subjects of nonchildbearing potential.
We found this trial at
1
site
Click here to add this to my saved trials
